|Bid||71.16 x 2200|
|Ask||71.46 x 1800|
|Day's range||71.18 - 71.87|
|52-week range||56.56 - 73.34|
|Beta (5Y monthly)||0.41|
|PE ratio (TTM)||17.43|
|Earnings date||26 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||2.84 (3.99%)|
|Ex-dividend date||14 Sep 2021|
|1y target est||75.84|
Dr. Arthur Caplan, NYU Langone Health, Division of Medical Ethics at NYU School of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus vaccines and booster shots.
The wild swings are enough to cause many investors to look for safe havens to park their hard-earned cash. Here's why those chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ). Prosper Junior Bakiny (AbbVie): Investors looking for safety in this volatile market can't go wrong with AbbVie.
Dr. Cedric Dark, Assistant Professor at Baylor College of Medicine & Board Member with Doctors for America, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.